Global Spine Biologics Market Research Report

The global spine biologics market has seen challenging and dynamic market conditions in recent years. The global spine biologics market is mainly driven by aging population and the increasing prevalence of rheumatoid and osteoarthritis.

The report analyzes the market in terms of technology into 5 segments, such as spinal allograft, demineralized bone matrix, bone morphogenetic proteins, bone substitutes, and machined bones. All these segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques. All the markets have been witnessing considerably high growth because of increase in patient pool and procedure numbers of osteoarthritis and rheumatoid arthritis.

The procedure volume growth is significantly high in the U.S., Germany, Brazil, India, China, and Mexico, among others, because of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and the increasing awareness amongst people. Owing to the recent developments and usage, North America constitutes the largest share in the global market, followed by Europe. The spine biologics market is experiencing significant growth in the Asian region as a result of the growing population, awareness of newly developed technologies, increased per capita income of the hospitals and the people, improved medical literacy, and tourism, among others.

The high initial cost and complicated machines of spine biologics are some of the major inhibitors that are slowing the growth rate of the market. The ageing population and the growing health concerns have led governments to take several initiatives, thereby providing several opportunities to this market.

Some of the key players in the market include Alphatec Spine Inc., DePuy Spine, Medtronic Inc., Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., and Zimmer Spine Inc., among others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

Customization Options:

Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:

Product Analysis:

• Usage pattern (in-depth trend analysis) of products (segment-wise)
• Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
• End-user adoption rate analysis of the products (segment-wise and country-wise)
• A comprehensive coverage of product approvals, pipeline products and product recalls

Epidemiology Data

• Country-specific prevalence of  spine osteoarthritis (OA) and rheumatoid arthritis (RA)
• Country-specific patient pool of  spine OA and RA
• Disease progression (pattern analysis)

Procedure Volume Data

• Spinal procedures performed annually in each country, tracked till sub-segment level
• The number of anterior or posterior cervical and thoracic fusion procedures performed in each country

Surgeons/Physicians Perception Analysis:

• Fast turn-around analysis of surgeons’ responses to market events and trends
• Pattern analysis of usage of bone cements (antibiotic and non-antibiotic) by physicians
• Surgeons’ opinions about products from different companies
• Surgeons’ qualitative inputs on epidemiology data

Brand/Product Perception Matrix:

• A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
• An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such as patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :Global Spine Biologics Market Research Report

* Enter the text from the image to the text box :